Hritvik Jain, Mohammed Dheyaa Marsool Marsool, Haleema Qayyum Abbasi, Samia Aziz Sulaiman, Adnan Safi, Yashdeep Lathwal, Shefali Mody, Jyoti Jain, Rishabh Baskara Salian, Siddhant Passey, Aman Goyal, Shrey Gole
Fluoroquinolones (FQs) are routinely administered antibiotics that have demonstrated an increased propensity to cause major adverse cardiovascular events (MACE). We conducted a systematic review aimed to investigate the association between FQ usage and the risk of MACE. A comprehensive literature search was conducted using PubMed, Scopus, and the Cochrane Library from inception to September 2023 to retrieve studies comparing FQ administration with placebo and reporting the occurrence of MACE. Relevant studies that explored the occurrence of MACE, defined as "acute myocardial infarction, stroke, cardiovascular mortality, arrhythmia, or heart failure" with FQ usage were eligible for inclusion...
April 30, 2024: Cardiology in Review